Metastatic Melanoma: Anti-Nodal Antibodies Plus Dacarbazine Promising
Friday, March 13, 2015 - 13:40
in Health & Medicine
Metastatic melanoma is the leading cause of skin cancer deaths in the United States because once has spread - metastasized - life expectancy for patients is dramatically shortened. Melanoma diagnosis and treatment has progressed a lot and the future looks even brighter but the current reference therapy for patients diagnosed with metastatic melanoma is Dacarbazine (DTIC), which is associated with relatively poor patient outcomes. read more